ImmunoMind
Cambridge, United States· Est.
Develops AI-powered platforms for immune system analysis and biomarker discovery to advance precision medicine.
Private Company
Total funding raised: $2.5M
About
Develops AI-powered platforms for immune system analysis and biomarker discovery to advance precision medicine.
AI / Machine Learning
Funding History
1Total raised:$2.5M
Seed$2.5M